Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.64 is 28% below its 5-year average of 14.72, near the low end of its 5-year range (8.72–22.09).
As of the fiscal period ended Tuesday, June 30, 2026. 30.64% below its 12-month average of 15.35.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.64.
QUICK RATIO (ACID-TEST)
10.64
QUICK RATIO (ACID-TEST) AVG TTM
15.35
QUICK RATIO (ACID-TEST) AVG 3Y
14.44
QUICK RATIO (ACID-TEST) AVG 5Y
14.72
QUICK RATIO (ACID-TEST) AVG 10Y
16.27
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-30.64%
CURRENT VS 3Y AVG
-26.30%
CURRENT VS 5Y AVG
-27.71%
CURRENT VS 10Y AVG
-34.57%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+217.75%
vs the sector median at left
Neurogene Inc.
Market Cap
$402.17M
Quick Ratio (Acid-Test)
10.64
TTM Avg
15.35
3Y Avg
14.44
5Y Avg
14.72
Market Cap
$404.24M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.95
3Y Avg
1.91
5Y Avg
2.07
Market Cap
$405.74M
Quick Ratio (Acid-Test)
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$397.99M
Quick Ratio (Acid-Test)
8.66
TTM Avg
7.11
3Y Avg
5.24
5Y Avg
5.24
Market Cap
$406.58M
Quick Ratio (Acid-Test)
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$396.93M
Quick Ratio (Acid-Test)
8.92
TTM Avg
6.16
3Y Avg
7.06
5Y Avg
7.06
Market Cap
$411.00M
Quick Ratio (Acid-Test)
2.64
TTM Avg
6.72
3Y Avg
6.86
5Y Avg
10.10
Market Cap
$411.21M
Quick Ratio (Acid-Test)
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$415.98M
Quick Ratio (Acid-Test)
9.44
TTM Avg
11.90
3Y Avg
14.34
5Y Avg
23.42
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | $402.17M | 10.64 | 15.35 | 14.44 | 14.72 |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | 1.98 | 1.95 | 1.91 | 2.07 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 8.13 | 16.34 | 21.67 | 17.16 |
| Carlsmed, Inc. (CARL)vs › | $397.99M | 8.66 | 7.11 | 5.24 | 5.24 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 9.89 | 6.34 | 6.34 | 6.34 |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | 8.92 | 6.16 | 7.06 | 7.06 |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 2.64 | 6.72 | 6.86 | 10.10 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 16.52 | 13.61 | 8.86 | 8.86 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 9.44 | 11.90 | 14.34 | 23.42 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 6.40 | 3.40 | 4.68 | 4.62 |
Quick Ratio
10.64
Excludes inventory
Current Ratio
10.64
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.64 |
| 2026-03-31 | 13.08 |
| 2025-12-31 | 16.55 |
| 2025-09-30 | 18.39 |
| 2025-06-30 | 18.07 |
| 2025-03-31 | 21.03 |
| 2024-12-31 | 20.84 |
| 2024-09-30 | 9.09 |
| 2024-06-30 | 12.17 |
| 2024-03-31 | 14.74 |
| 2023-12-31 | 8.72 |
| 2023-09-30 | 15.33 |
| 2023-06-30 | 9.12 |
| 2023-03-31 | 11.97 |
| 2022-12-31 | 12.74 |
| 2022-09-30 | 10.63 |
| 2022-06-30 | 12.78 |
| 2022-03-31 | 17.16 |
| 2021-12-31 | 16.67 |
| 2021-09-30 | 17.40 |
| 2021-06-30 | 22.09 |
| 2021-03-31 | 21.57 |
| 2020-12-31 | 24.66 |
| 2020-09-30 | 20.88 |
| 2020-06-30 | 20.73 |
| 2020-03-31 | 24.92 |
| 2019-12-31 | 30.28 |
| 2019-09-30 | 26.35 |
| 2019-06-30 | 63.17 |
| 2019-03-31 | 20.81 |
| 2018-12-31 | 16.68 |
| 2018-09-30 | 8.12 |
| 2018-06-30 | 7.73 |
| 2018-03-31 | 10.07 |
| 2017-12-31 | 9.93 |
| 2017-09-30 | 17.23 |
| 2017-06-30 | 16.26 |
| 2017-03-31 | 21.02 |
| 2016-12-31 | 10.87 |
| 2016-09-30 | 17.12 |
